Atypical acute promyelocytic leukemia with tripartite fusion gene <i>PML::RARG::LINE-L2a</i> is resistant to ATRA but sensitive to arsenic-based therapy

Atypical acute promyelocytic leukemia with tripartite fusion gene <i>PML::RARG::LINE-L2a</i> is resistant to ATRA but sensitive to arsenic-based therapy

Not available.

Saved in:

Bibliographic Details
Main Authors:	Sanyun Wu, Yalan Yu, Xiang Lin, Xiaosu Zhou, Yuanyuan Zhou, Ping Luo, Hui Shen, Jing He, Li Liu, Xiaoyan Liu, Dong Lei Zhang, Yanan Liu, Hui Xiao, Fuling Zhou, Hongxing Liu, Zhanglin Zhang
Format:	Article
Language:	English
Published:	Ferrata Storti Foundation 2025-06-01
Series:	Haematologica
Online Access:	https://haematologica.org/article/view/12106
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effects of arsenic on the topology and solubility of promyelocytic leukemia (PML)-nuclear bodies.
by: Seishiro Hirano, et al.
Published: (2022-01-01)

Mutation in the Unrearranged PML Allele Confers Resistance to Arsenic Trioxide in Acute Promyelocytic Leukemia
by: Pei-Han Yu, et al.
Published: (2025-01-01)

Oncogenic role of RARG rearrangements in acute myeloid leukemia resembling acute promyelocytic leukemia
by: Feng Wang, et al.
Published: (2025-01-01)

Penile ulcer ATRA related in patient with acute promyelocytic leukemia
by: Irfan Yavasoglu, et al.
Published: (2012-01-01)

Acute promyelocytic leukemia lacking t(15;17): Molecular evidence of atypical PML/RAR-α transcriptional variant by gene sequencing
by: Đorđević Vesna, et al.
Published: (2020-01-01)

ATRA USE RELATED PENILE ULCER IN PATIENT WITH ACUTE PROMYELOCYTIC LEUKEMIA
by: Irfan Yavasoglu, et al.
Published: (2014-08-01)

Rapid Detection of <i>PML::RARA</i> Fusions in Acute Promyelocytic Leukemia: CRISPR/Cas9 Nanopore Sequencing with Adaptive Sampling
by: William Middlezong, et al.
Published: (2024-12-01)

Cardiac Glycosides Activate the Tumor Suppressor and Viral Restriction Factor Promyelocytic Leukemia Protein (PML).
by: Snezana Milutinovic, et al.
Published: (2016-01-01)

HIF factors cooperate with PML‐RARα to promote acute promyelocytic leukemia progression and relapse
by: Nadia Coltella, et al.
Published: (2014-04-01)

The boundaries between PML and PML-IRIS: difficult to define, pathology may predict
by: Jiamin Chen, et al.
Published: (2025-06-01)

Detection of cytogenetically cryptic PML-RARA fusion in acute promyelocytic leukemia by rapid next generation sequencing
by: Hailee St. Louis, et al.
Published: (2025-08-01)

A Rare Complication in a Patient with Acute Promyelocytic Leukemia; ATRA and Posaconazole Associated Hypercalcemia
by: Yeşim Yiğit, et al.
Published: (2024-09-01)

Challenging management of severe differentiation syndrome in pediatric acute promyelocytic leukemia treated with ATRA/ATO
by: Alessandro Molinaro, et al.
Published: (2022-02-01)

Venetoclax for an ATRA and ATO resistance acute promyelocytic leukemia patient with TNRC18::RARA fusion gene
by: Weina Li, et al.
Published: (2024-01-01)

DISTRIBUTION OF DIFFERENT PML/RARΑ BCR ISOFORMS IN INDIAN ACUTE PROMYELOCYTIC LEUKAEMIA (APL) PATIENTS AND CLINICOHEMATOLOGICAL CORRELATION
by: Tathagata Chatterjee, et al.
Published: (2013-12-01)

Acute promyelocytic leukemia with <i>TTMV::RARA</i> fusion potentially responds to all-trans retinoic acid/arsenic trioxide treatment
by: Qingyu Xu, et al.
Published: (2025-01-01)

The interaction between herpes simplex virus 1 genome and promyelocytic leukemia nuclear bodies (PML-NBs) as a hallmark of the entry in latency
by: Patrick Lomonte
Published: (2016-11-01)

PML-RARA NORMALIZED COPY NUMBER AFTER CONSOLIDATION THERAPY CAN STRATIFY THE RISK OF RELAPSE IN ADULT EGYPTIAN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA
by: yasser hassan elnahass
Published: (2014-08-01)

CPSF6-RARγ interacts with histone deacetylase 3 to promote myeloid transformation in RARG-fusion acute myeloid leukemia
by: Tianhui Liu, et al.
Published: (2025-01-01)

Pattern of Expression of PML-RARα Transcripts in Acute Promyelocytic Leukemia Patients and Its Correlation with Overall Survival: A Retrospective Study from Western India
by: Shweta Gondha, et al.
Published: (2025-06-01)

Venetoclax plus arsenic and all-trans retinoic acid in patients with relapsed/refractory acute promyelocytic leukemia
by: Bingqian Jiang, et al.
Published: (2025-07-01)

Arsenic Trioxide Treatment during Pregnancy for Acute Promyelocytic Leukemia in a 22-Year-Old Woman
by: Claire Cochet, et al.
Published: (2020-01-01)

Vivir para atrás: Manuel de Castro en los <i>Cronicones montevideanos</i>
by: Valentina Lorenzelli
Published: (2014-09-01)

OVERVIEW OF CLASS-I TRIPARTITE MOTIF (TRIM) PROTEINS SPECIFICALLY TRIM67
by: S. N. Panhwar, et al.
Published: (2024-12-01)

Comparison of newly diagnosed and relapsed patients with acute promyelocytic leukemia treated with arsenic trioxide: insight into mechanisms of resistance.
by: Ezhilarasi Chendamarai, et al.
Published: (2015-01-01)

Severe acute axonal neuropathy following treatment with arsenic trioxide for acute promyelocytic leukemia: a case report
by: Marcus Kuhn, et al.
Published: (2016-05-01)

Variations of Orsodachna Atra—Coleoptera
by: C. A. Frost
Published: (1912-01-01)

Assessment of a PML Boundary Condition for Simulating an MRI Radio Frequency Coil
by: Yunsuo Duan, et al.
Published: (2008-01-01)

Isochromosome der(17)(q10)t(15;17) in acute promyelocytic leukemia resulting in an additional copy of the RARA-PML and loss of one p53 gene: Report of two cases and literature review
by: Đorđević Vesna, et al.
Published: (2019-01-01)

Prevalence of progressive multifocal leukoencephalopathy (PML) in adults and children with systemic lupus erythematosus
by: Laura Geraldino-Pardilla, et al.
Published: (2020-10-01)

Impact of Arsenic Stress on the Antioxidant System and Photosystem of <i>Arthrospira platensis</i>
by: Jiawei Liu, et al.
Published: (2024-12-01)

A phase II study evaluating the role of bortezomib in the management of relapsed acute promyelocytic leukemia treated upfront with arsenic trioxide
by: Uday Kulkarni, et al.
Published: (2020-04-01)

Successful Control of Disseminated Intravascular Coagulation by Recombinant Thrombomodulin during Arsenic Trioxide Treatment in Relapsed Patient with Acute Promyelocytic Leukemia
by: Motohiro Shindo, et al.
Published: (2012-01-01)

Secreted miRNAs in the tripartite neuromuscular junction
by: Liangsheng Lu, et al.
Published: (2019-06-01)

Inhibition of Zymosan-Induced Inflammatory Factors Expression by ATRA Nanostructured Lipid Carriers
by: Hongyan Zhou, et al.
Published: (2016-01-01)

On the existence of tripartite graphs and n-partite graphs
by: Guo Jiyun, et al.
Published: (2024-12-01)

Biooxidation of Arsenopyrite by <i>Acidithiobacillus ferriphilus</i> QBS 3 Exhibits Arsenic Resistance Under Extremely Acidic Bioleaching Conditions
by: Run Liu, et al.
Published: (2025-05-01)

Down Regulation of DHFR Promoter Activity by PML Transcription Repressor
Published: (2004-09-01)

Arsenic trioxide as an inducer of immunogenic cell death
by: Oliver Kepp, et al.
Published: (2023-12-01)

A blockchain based efficient incentive mechanism in tripartite cyber threat intelligence service marketplace
by: Yuan Zhou, et al.
Published: (2025-06-01)